+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020

  • ID: 5189459
  • Report
  • October 2020
  • Region: Global
  • 386 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • 1BioCorRx Inc
  • AzureBio SL
  • DelSite, Inc. (Inactive)
  • Ionic Pharmaceuticals LLC
  • Novosanis NV
  • TCB medical devices
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's Medical Devices sector report, “Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020“. Injectable Drug Delivery Devices are defined as administration of a drug into patient’s blood through a delivery device.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Injectable Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Injectable Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Injectable Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 1BioCorRx Inc
  • AzureBio SL
  • DelSite, Inc. (Inactive)
  • Ionic Pharmaceuticals LLC
  • Novosanis NV
  • TCB medical devices

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Injectable Drug Delivery Overview
3 Products under Development
3.1 Injectable Drug Delivery - Pipeline Products by Stage of Development
3.2 Injectable Drug Delivery - Pipeline Products by Segment
3.3 Injectable Drug Delivery - Pipeline Products by Territory
3.4 Injectable Drug Delivery - Pipeline Products by Regulatory Path
3.5 Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Injectable Drug Delivery - Ongoing Clinical Trials
4 Injectable Drug Delivery - Pipeline Products under Development by Companies
4.1 Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Injectable Drug Delivery - Pipeline Products by Stage of Development
5 Injectable Drug Delivery Companies and Product Overview6 Injectable Drug Delivery- Recent Developments 2137 Appendix
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
List of Tables
Table 1: Injectable Drug Delivery - Pipeline Products by Stage of Development
Table 2: Injectable Drug Delivery - Pipeline Products by Segment
Table 3: Injectable Drug Delivery - Pipeline Products by Territory
Table 4: Injectable Drug Delivery - Pipeline Products by Regulatory Path
Table 5: Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
Table 6: Injectable Drug Delivery - Ongoing Clinical Trials
Table 7: Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
Table 8: Injectable Drug Delivery - Pipeline Products by Stage of Development
Table 9: Adalvo Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Icatibant Pre-Filled Syringe - Product Status
Table 11: Icatibant Pre-Filled Syringe - Product Description
Table 12: Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Symjepi - Product Status
Table 14: Symjepi - Product Description
Table 15: AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Adrenacard Auto-Injector - Product Status
Table 17: Adrenacard Auto-Injector - Product Description
Table 18: AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 19: ARAI-2PAM - Product Status
Table 20: ARAI-2PAM - Product Description
Table 21: Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: NOVADUR Intravitreal Implant - Product Status
Table 23: NOVADUR Intravitreal Implant - Product Description
Table 24: Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview
Table 25: SQJCT - Product Status
Table 26: SQJCT - Product Description
Table 27: Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Methotrexate Auto Injector - Ectopic Pregnancy - Product Status
Table 29: Methotrexate Auto Injector - Ectopic Pregnancy - Product Description
Table 30: QuickShot Selatogrel - Product Status
Table 31: QuickShot Selatogrel - Product Description
Table 32: Rescue Pen - Product Status
Table 33: Rescue Pen - Product Description
Table 34: Teriparatide Disposable Pen Injector - Product Status
Table 35: Teriparatide Disposable Pen Injector - Product Description
Table 36: Vibex QS M - Product Status
Table 37: Vibex QS M - Product Description
Table 38: Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Apollo - Product Status
Table 40: Apollo - Product Description
Table 41: Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Artemes Magnetic Injection System - Product Status
Table 43: Artemes Magnetic Injection System - Product Description
Table 44: Ascendis Pharma A/S Pipeline Products & Ongoing Clinical Trials Overview
List of Figures
Figure 1: Injectable Drug Delivery - Pipeline Products by Stage of Development
Figure 2: Injectable Drug Delivery - Pipeline Products by Segment
Figure 3: Injectable Drug Delivery - Pipeline Products by Territory
Figure 4: Injectable Drug Delivery - Pipeline Products by Regulatory Path
Figure 5: Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
Figure 6: Injectable Drug Delivery - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Adalvo
  • Adamis Pharmaceuticals Corp
  • AdrenaCard, Inc.
  • AktiVax Inc.
  • Allergan Ltd
  • Alsensa ApS
  • Antares Pharma Inc
  • Aquavit Pharmaceuticals Inc
  • Artemes Technologies, Inc.
  • Ascendis Pharma A/S
  • ASCIL Biopharm
  • ASIS Corp
  • AzureBio SL
  • Bespak Europe Ltd
  • Biocorp Production SA
  • 1BioCorRx Inc
  • BioRestorative Therapies Inc
  • Bioxis Pharmaceuticals
  • Brigham and Women's Hospital
  • Burke Pharmaceuticals LLC
  • Calla Health Foundation
  • Callisyn Biomedical Inc
  • Cambridge Consultants Ltd
  • Camurus AB
  • Case Western Reserve University
  • Cincinnati Children's Hospital Medical Center
  • Clearside BioMedical Inc
  • DALI Medical Devices Ltd.
  • DelSite, Inc. (Inactive)
  • Drexel University
  • Duoject Medical Systems Inc
  • Ecole Polytechnique Federale de Lausanne
  • Elcam Medical
  • EmboMedics Inc
  • Embryyo Technologies Pvt Ltd
  • Emergent BioSolutions Inc
  • EP Global Communications Inc (Inactive)
  • Eveon SAS
  • EyePoint Pharmaceuticals Inc
  • FHC Inc
  • GeneSYS-ID Inc
  • Georgia Institute of Technology
  • Ghent University
  • Globe Medical Tech Inc (Inactive)
  • Hoffmann-La Roche Inc
  • Inovio Pharmaceuticals Inc
  • InVivo Therapeutics Corp
  • Ionic Pharmaceuticals LLC
  • JCR Pharmaceuticals Co Ltd
  • komarik
  • Kyowa Kirin Ltd
  • Lohmann Therapie-Systeme AG
  • 5LyoGo
  • Mallinckrodt Plc
  • Mercator MedSystems Inc
  • Mertiva AB
  • Midas Pharma GmbH
  • Milestone Scientific Inc
  • 5Millendo Therapeutics Inc
  • Morimoto Pharma Co Ltd
  • NanoPass Technologies Ltd
  • Novo Nordisk AS
  • Novosanis NV
  • Osteo Pharma BV
  • Oval Medical Technologies Ltd
  • Owen Mumford Ltd
  • Palatin Technologies Inc
  • Particle Therapeutics Ltd
  • Portal Instruments Inc
  • Prohibix LLC
  • QuiO Technologies LLC
  • Regeneron Pharmaceuticals Inc
  • RepliCel Life Sciences Inc
  • Rescitech Vision Pvt Ltd
  • RetinaPharma Technologies Inc
  • Sapporo Medical University School of Medicine
  • Schott AG
  • Subcuject ApS
  • Sunshine Guojian Pharmaceutical Shanghai Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • TCB medical devices
  • Terumo Corp
  • Teva Pharmaceutical Industries Ltd
  • TheraKine Inc (Inactive)
  • Twin Star Medical Inc
  • Unilife Corporation
  • University of Calgary
  • University of California San Diego
  • University of California San Francisco
  • University of Delaware
  • University of Dundee
  • University of Florida
  • University of New Mexico
  • University of Saskatchewan
  • University of Texas at Austin
  • Vanderbilt University
  • West Pharmaceutical Services Inc
  • Windgap Medical Inc
  • XERIS Pharmaceuticals Inc
  • Ypsomed Holding AG
  • Zosano Pharma Corp
Note: Product cover images may vary from those shown